Patient Guide: A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 38 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06919965
Status: 🟢 Enrolling Now
Condition: Non-Muscle Invasive Bladder Neoplasms
Phase: PHASE3

Where You Can Participate

This study is available at 38 locations across the country.

Top locations include:
  • • Atlanta, Georgia
  • • Omaha, Nebraska
  • • Centerville, Ohio
  • • And 35 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer - Join Clinical Trial NCTNCT06919965

How to Join This Clinical Trial - NCTNCT06919965

Learn how to participate in this PHASE3 trial studying an investigational therapy for Non-Muscle Invasive Bladder Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Muscle Invasive Bladder Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Muscle Invasive Bladder Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06919965 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 38 locations. Find a study site near you:

Clinical Research Site

Atlanta, Georgia 30328 - United States

Status: RECRUITING

Clinical Research Site

Omaha, Nebraska 68114 - United States

Status: RECRUITING

Clinical Research Site

Centerville, Ohio 45459 - United States

Status: RECRUITING

Clinical Research Site

Middleburg Heights, Ohio 44130 - United States

Status: RECRUITING

Clinical Research Site

Bala-Cynwyd, Pennsylvania 19004 - United States

Status: RECRUITING

Clinical Research Site

Lancaster, Pennsylvania 17604 - United States

Status: RECRUITING

Clinical Research Site

Germantown, Tennessee 38138 - United States

Status: RECRUITING

Clinical Research Site

Austin, Texas 78745 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: RECRUITING

Clinical Research Site

Natal, 59062 000 - Brazil

Status: RECRUITING

And 28 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Non-Muscle Invasive Bladder Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships